Study designs of evaluations included in the review
Case series, cohorts, case-control studies, controlled clinical trials and randomised controlled trials (RCT) with more than 20 participants were eligible for inclusion.
Specific interventions included in the review
Studies of ESWT were eligible for inclusion. Patients with calcific RC tendonitis generally received from 1 to 8 sessions of ESWT at weekly intervals under regional, local or no anaesthetic, using some type of guidance. Patients with non-calcific RC tendonitis received 3 sessions of ESWT at weekly or monthly intervals (where stated); only one study used local anaesthetic and only one study used some type of guidance.
Participants included in the review
Studies of patients with calcific or non-calcific RC tendonitis were eligible for inclusion. Where reported, the mean age of the participants ranged from 45 to 53 years, and in the majority of studies more than half of the participants were female. Most of the participants had chronic disease (lasting 3 months or more) and most had not responded to conservative treatment.
Outcomes assessed in the review
The most common outcome used in the included studies was the Constant Score. This assessed pain, activities of daily living, shoulder motion and power. Studies also assessed subjective improvement and disability. The reviewers decided that patients should be followed up for at least 3 months in order to describe a clinically relevant result.
How were decisions on the relevance of primary studies made?
Two reviewers independently selected studies and resolved any disagreements on inclusion through discussion.